CryptoAlias

CryptoAlias

ICO Ended
13,956 Views
It is an alias system for complex Blockchain addresses. You get a unique alias and associate your blockchain address with it. Instead of using your blockchain address, your clients can start using your simple and personalized alias. Alternatively, your clients can continue to use your blockchain address. However, when they input it in a wallet, your alias will appear and will give them the confidence of having introduced the right characters.
5.1
TOTAL SCORE
3
PRODUCT

(weight: 25%)

4
BUSINESS

(weight: 25%)

6.5
ICO PROFILE

(weight: 25%)

10
TEAM PROOF

(weight: 10%)

Get widget
General
Website: Visit
White paper: Read
ICO Time: 20 Dec 2017 - 20 Feb 2018
Country: Romania
Token info
Ticker: ALS
Platform: Ethereum
Token Type: ERC20
Available for sale: 75,000,000 ALS (75%)
Financial
Raised $ 55,697
ICO Price: 1 ETH = 1000-1250 ALS
Accepting: ETH
Screenshots taken on 6 Feb 2018
Dumitru Berestean
CEO
Participates in a number of projects
Victor Binzari
MARKETING AND COMMUNICATIONS
Participates in a number of projects
Ciprian Ciubotaru
BLOCKCHAIN SPECIALIST
Participates in a number of projects
Arthur Rusu
QA ANALYST
Participates in a number of projects

Advisors (1)

Silviu Nedelciuc
TECHNICAL ADVISOR
Participates in a number of projects
HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Active
Rivalz
Rivalz is redefining AI infrastructure by creating an AI Intel Layer to unlock new agentic economies. Built on a dual-chain DePIN architecture using Dymension and Arbitrum, Rivalz addresses one of the biggest bottlenecks in AI today: access to AI-ready, verifiable, and secure data. As we envision the web3 space to become agentic and overtake humans in the amount of transactions over time, what Rivalz is building is key for enabling this future. The core challenge that Rivalz is addressing is the need for AI-ready, verifiable and accessible data and later on intelligence. Rivalz offers a hybrid solution combining decentralized storage and high-speed agent-centric connectivity networks that cater specifically to AI's demands, ushering in the era of the agentic economy.
Upcoming
Co-DEX Exchange
Co-DEX is a Decentralized trading platform for cryptocurrencies, built on vanguard security infrastructure and using a revolutionary system. Co-DEX is an exchange created by the community, for the community, thus Co-DEX will be the first exchange that will apply a NO FEES policy on transactions, the users being required to cover solely the transaction cost of the miners and/or validators that register the action on the blockchains. Experience direct peer-to-peer trading without the security risk of trusting a third party, thus having complete control of your assets at any time.
Upcoming
Verifier
Verifier is an innovative technology designed to verify identity, events, deals, and any other kind of data. This is a blockchain based solution that verifies data quickly, accurately, trustworthy, and securely.
Upcoming
Acta Finance
The first Cross-Chain Interoperable DeFi Ecosystem, built natively on Avalanche The ActaFi Ecosystem brings a complete DeFi suite that incentivises user-base growth and motivates the user activity, offering both DeFi products and features in a single ecosystem. Every interaction within the ActaFi Ecosystem is executed on-chain, by smart contracts.
Upcoming
Minerva
Minerva is the world's first reverse merchant processor. We pay transaction fees to approved businesses integrated within the Minerva economy, we don't charge them. Minerva is a platform designed to incentivize the adoption of its OWL token with a new and disruptive economic model.
Upcoming
MediLOT
MediLOT is a health data protocol that aims to solve the concerns of Electronic Health Records (EHR). Current EHR systems are fragmented, centralised and lack patient ownership. Through a dual blockchain solution, MediLOT incorporates Artificial Intelligence capabilities onboard its control and data layers which allows the equitable sharing of health data. The MediLOT ecosystem will consist of patients, healthcare providers, researchers and commercial companies.